Unknown Manufacturer
口服前药（prodrug），在细胞内转化为活性代谢物后抑制 NLRP3 炎症小体（inflammasome）组装，阻断上游 IL-1β/IL-6/IL-18 炎症级联反应。
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
